Advisory Services Network’s Blueprint Medicines BPMC Stock Holding History

Advisory Services Network’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-247	Closed	-$22.8K	–	1735
2023 Q4	$22.8K	Buy	+247	New	+$16K	﹤0.01%	2455
2023 Q2	–	Sell	-240	Closed	-$10.8K	–	1724
2023 Q1	$10.8K	Sell	240 -611	-72%	-$27.5K	﹤0.01%	2837
2022 Q4	$37.3K	Buy	+851	New	+$40.8K	﹤0.01%	2136
2021 Q3	–	Sell	-50	Closed	-$4K	–	1631
2021 Q2	$4K	Buy	+50	New	+$4.58K	﹤0.01%	3112
2021 Q1	–	Sell	-31	Closed	-$3K	–	1490
2020 Q4	$3K	Sell	31 -68	-69%	-$7.17K	﹤0.01%	2852
2020 Q3	$9K	Buy	+99	New	+$7.62K	﹤0.01%	2466
2020 Q2	–	Sell	-86	Closed	-$5K	–	1243
2020 Q1	$5K	Buy	+86	New	+$5.53K	﹤0.01%	2457

Other funds holding BPMC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisory Services Network's BPMC Position: Q1 2024 in Review

Advisory Services Network sold out of Blueprint Medicines (BPMC) in Q1 2024, closing a stake of 247 shares — an estimated $22.8K sold.

Advisory Services Network first reported a position in BPMC in Q1 2020 and held it in 7 quarters. The position peaked at $37.3K in Q4 2022. 283 funds tracked by Wall St. Rank hold BPMC as of Q1 2024.

Advisory Services Network reported no remaining Blueprint Medicines position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 247 Blueprint Medicines shares in Q1 2024, an estimated $22.8K.
Advisory Services Network first reported a position in Blueprint Medicines in Q1 2020 and held it in 7 quarters.
Advisory Services Network's Blueprint Medicines position peaked at $37.3K in Q4 2022.
283 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.